Noto

Name

Noto

Legal name

Noto.ai, Inc.

Website

https://noto.ai

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Specialty Behavioral Health Platform

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

• Specialty therapy platform
• Behavioral health services
• AI-enabled care delivery
• Mental health network
• ERP therapy provider

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Insurance reimbursement / B2B payer contracts: Noto specialty therapy brands partner with health insurers (BlueCross BlueShield, Cigna, Kaiser Permanente, Aetna) covering 70+ payers nationally to serve their members with complex conditions. Services are billed through insurance, with Noto managing full-time specialty therapy networks on behalf of payer partners.
2. Value-based care savings: NOCD achieved $3,430 per member per year savings compared to standard care ($925 vs $4,355 annual cost increase per member). Analysis conducted with Optum in 2025. This suggests value-based contracting with payers based on cost savings and clinical outcomes.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Noto operates an AI-enabled platform that builds, scales, and manages specialty therapy brands for complex psychiatric and behavioral conditions. The platform partners with health insurers to identify and enroll members, deploys AI agents across care operations, and operates full-time specialty therapist networks delivering evidence-based treatments such as ERP therapy. Specialty therapy brands under the Noto umbrella include NOCD for OCD and related conditions and Rebound for trauma disorders.

Product overview

Noto is an AI-enabled platform that transforms specialty therapy to end the mental health crisis. The platform operates a multi-brand portfolio model where each specialty condition (OCD, trauma, panic, eating disorders) has its own branded therapy offering, all powered by shared Noto infrastructure. The core Noto AI Platform enables partner integration with 70+ national payers, AI-powered member identification campaigns, community engagement for enrollment, and management of full-time specialty therapist networks. NOCD (treatmyocd.com) is Noto's first and flagship specialty brand serving OCD and related disorders at scale, followed by Rebound for trauma disorders. Additional specialties for panic disorder and eating disorders are in development.

Differentiator

Problem solved

Functional benefit

Products and services

• Noto AI Platform AI-enabled infrastructure platform that powers Noto's specialty therapy brands by enabling payer partnerships, AI-powered member identification and enrollment campaigns, community engagement, and management of full-time specialty therapist networks and care teams.
• NOCD Noto's first specialty therapy brand focused on OCD and related conditions; provides full-stack OCD treatment including ERP therapy, clinical training, and continuing education, and is the leader in serving the OCD population at scale.
• Rebound Noto specialty therapy brand focused on trauma disorders, including PTSD and related conditions; currently in commercialization phase leveraging the infrastructure built from scaling NOCD.
• Panic Disorder Specialty Specialty therapy brand in development for panic disorder, currently in protocol validation phase.
• Eating Disorders Specialty Specialty therapy brand in development for eating disorders, currently in early development stages.

Quantifiable outcome

• 138 million lives covered by payers (up from <1 million)
• +6 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• BlueCross BlueShieldcoreChannel Partner/ Reseller/ DistributorMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
• CignacoreChannel Partner/ Reseller/ DistributorMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
• Kaiser PermanentecoreChannel Partner/ Reseller/ DistributorMajor integrated health system partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
• AetnacoreChannel Partner/ Reseller/ DistributorMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
• NOCDcoreStrategic or Co-development PartnerNoto's first specialty therapy brand and the leader in serving OCD and related conditions. NOCD was the proof of concept for Noto's platform model, demonstrating dramatic improvements in payer coverage, wait times, outcomes, and costs. The entire OCD treatment journey from identification to maintenance therapy is owned by NOCD and enabled by Noto.
• ReboundcoreStrategic or Co-development PartnerNoto specialty therapy brand focused on trauma disorders (7.0% prevalence). Currently in the commercialization phase, leveraging the infrastructure built from scaling NOCD.
• OptumminorStrategic or Co-development PartnerHealthcare analytics company that collaborated on a 2025 study demonstrating $3,430 per member per year savings achieved by NOCD compared to standard care ($925 vs $4,355 annual cost increase per member).

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Two Chairs: Two Chairs is a therapy provider that partners with payers and employers to deliver in-network outpatient behavioral health. It shares Noto's payer-contracted specialty therapy model and B2B2C distribution approach.
• Sondermind: Sondermind operates a hybrid in-person and virtual therapy network contracted with insurers to deliver outpatient mental health services. It is a direct peer on payer-contracted specialty therapy infrastructure.
• Spring Health: Spring Health provides mental health benefits to employers and health plans with a precision-matching model across therapy, coaching, and medication. Like Noto, it sells specialty care into payer contracts at scale and competes for similar B2B2C relationships.
• Cerebral: Cerebral is a virtual mental health platform focused on therapy and medication management for anxiety, depression, and ADHD, with payer and direct-pay channels. It overlaps with Noto in payer-partnered behavioral health delivery, though with more emphasis on medication management.
• Brightside Health: Brightside Health is a telehealth platform focused on anxiety and depression treatment combining therapy and medication, sold to payers and employers. It is comparable to Noto in delivering specialty psychiatric care via payer contracts.
• Talkspace: Talkspace is a publicly traded online therapy platform that contracts with insurers and employers to deliver behavioral health services. It is a direct peer on the virtual therapy / payer partnership axis where Noto competes.
• Lyra Health: Lyra Health is a B2B2C mental health benefits platform that partners with employers and payers to deliver therapy and coaching services. It is the closest direct competitor to Noto, operating a similar payer-contracted specialty therapy model.
• Headspace Health: Headspace Health (formed by the Ginger + Headspace merger) is a digital mental health platform serving employers, payers, and consumers with therapy, coaching, and self-care. It competes with Noto for payer relationships and member mindshare.

Broad incumbents

• Magellan Health: Magellan Health is a managed behavioral health care organization serving health plans and employers at scale. It is a broad incumbent peer, with Noto's CRO having previously led payer relations there.
• Optum Behavioral Health: Optum (UnitedHealth Group) operates the largest US behavioral health network and payer-aligned care delivery platform. It is a broad incumbent that competes with Noto in payer contracting and validated NOCD savings via its 2025 study.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/notoai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noto